Author Correction: METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N6-methyladenosine-dependent YTHDF binding
Wei Wang(Harbin Medical University), Zhimin Lu(Shandong Sport University), Dong Guo(Zhejiang Cancer Hospital), Shugeng Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Xue(Anhui Medical University), Yibo Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Yannan Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Rongxuan Zhu(Shanghai Jiao Tong University), Jie Wang(Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou)), Fei Shao(Qingdao University), Gaoxiang Zhao(Qingdao University), Xueying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Juhong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Yingli Sun(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 8
Related Papers
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2023|1k
Lipid metabolism and cancer
|The Journal of Experimental Medicine|2020|981
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
|Nature Medicine|2004|956
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity
|Journal of Biological Chemistry|2007|871
Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC
|Journal of Thoracic Oncology|2020|415